Shigehiro Kokubu

1.8k total citations
59 papers, 1.1k citations indexed

About

Shigehiro Kokubu is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Shigehiro Kokubu has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hepatology, 28 papers in Epidemiology and 25 papers in Surgery. Recurrent topics in Shigehiro Kokubu's work include Liver Disease Diagnosis and Treatment (26 papers), Liver Disease and Transplantation (25 papers) and Hepatocellular Carcinoma Treatment and Prognosis (23 papers). Shigehiro Kokubu is often cited by papers focused on Liver Disease Diagnosis and Treatment (26 papers), Liver Disease and Transplantation (25 papers) and Hepatocellular Carcinoma Treatment and Prognosis (23 papers). Shigehiro Kokubu collaborates with scholars based in Japan, United States and China. Shigehiro Kokubu's co-authors include Hisashi Hidaka, Akitaka Shibuya, Takahide Nakazawa, Masaaki Watanabe, Katsunori Saigenji, Koji Ono, Yusuke Okuwaki, Yoshiaki Tanaka, Juichi Takada and Tsutomu Minamino and has published in prestigious journals such as PLoS ONE, The American Journal of Gastroenterology and American Journal of Roentgenology.

In The Last Decade

Shigehiro Kokubu

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigehiro Kokubu Japan 17 945 569 366 137 127 59 1.1k
Marta Barrufet Spain 13 884 0.9× 589 1.0× 481 1.3× 97 0.7× 191 1.5× 24 1.2k
Takahide Nakazawa Japan 20 1.1k 1.2× 691 1.2× 327 0.9× 125 0.9× 150 1.2× 60 1.4k
Joon Hyoek Lee South Korea 19 1.1k 1.2× 733 1.3× 573 1.6× 95 0.7× 242 1.9× 45 1.5k
Yasukiyo Sumino Japan 19 590 0.6× 438 0.8× 248 0.7× 168 1.2× 161 1.3× 126 1.0k
Shintaro Takaki Japan 20 954 1.0× 601 1.1× 352 1.0× 70 0.5× 131 1.0× 77 1.2k
Xavier Adhoute France 17 784 0.8× 748 1.3× 199 0.5× 106 0.8× 127 1.0× 52 1.2k
Yi‐You Chiou Taiwan 21 1.3k 1.4× 939 1.7× 513 1.4× 100 0.7× 194 1.5× 49 1.6k
Xiao Li China 16 499 0.5× 373 0.7× 373 1.0× 75 0.5× 129 1.0× 94 821
Makoto Tanikawa Japan 20 981 1.0× 938 1.6× 227 0.6× 46 0.3× 95 0.7× 69 1.4k
Yohei Koizumi Japan 19 887 0.9× 901 1.6× 282 0.8× 112 0.8× 117 0.9× 93 1.3k

Countries citing papers authored by Shigehiro Kokubu

Since Specialization
Citations

This map shows the geographic impact of Shigehiro Kokubu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigehiro Kokubu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigehiro Kokubu more than expected).

Fields of papers citing papers by Shigehiro Kokubu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigehiro Kokubu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigehiro Kokubu. The network helps show where Shigehiro Kokubu may publish in the future.

Co-authorship network of co-authors of Shigehiro Kokubu

This figure shows the co-authorship network connecting the top 25 collaborators of Shigehiro Kokubu. A scholar is included among the top collaborators of Shigehiro Kokubu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigehiro Kokubu. Shigehiro Kokubu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugimoto, Katsutoshi, Kento Imajo, Hidekatsu Kuroda, et al.. (2024). Microwave ablation vs. single-needle radiofrequency ablation for the treatment of HCC up to 4 cm: A randomized-controlled trial. JHEP Reports. 7(1). 101269–101269. 4 indexed citations
2.
Okubo, Hironao, Hitoshi Ando, Hiroaki Saito, et al.. (2020). Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma. PLoS ONE. 15(3). e0229772–e0229772. 17 indexed citations
3.
Okubo, Hironao, et al.. (2019). Plasma concentration and efficacy of tolvaptan in cirrhotic patients with refractory ascites. Journal of Pharmacological Sciences. 139(4). 373–376. 5 indexed citations
4.
Kobayakawa, Masao, Shigehiro Kokubu, Shozo Hirota, et al.. (2017). Short-Term Safety and Efficacy of Balloon-Occluded Retrograde Transvenous Obliteration Using Ethanolamine Oleate: Results of a Prospective, Multicenter, Single-Arm Trial. Journal of Vascular and Interventional Radiology. 28(8). 1108–1115.e2. 21 indexed citations
5.
Nakazawa, Takahide, Hisashi Hidaka, Juichi Takada, et al.. (2013). Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib. European Journal of Gastroenterology & Hepatology. 25(6). 683–689. 68 indexed citations
6.
Hidaka, Hisashi, Takahide Nakazawa, Guoqin Wang, et al.. (2011). Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: a randomized, controlled trial. Journal of Gastroenterology. 47(2). 118–126. 33 indexed citations
7.
Watanabe, Norihito, Atsushi Toyonaga, Seiichiro Kojima, et al.. (2010). Current status of ectopic varices in Japan: Results of a survey by the Japan Society for Portal Hypertension. Hepatology Research. 40(8). 763–776. 83 indexed citations
8.
Morimoto, Takashi, Kai‐Yuan Fu, Yuko Izumi, et al.. (2010). Endoscopic hemostasis with hemoclips for active gastric variceal bleeding. Endoscopy. 42(S 02). E333–E334. 2 indexed citations
9.
Hidaka, Hisashi, Shigehiro Kokubu, Takahide Nakazawa, et al.. (2009). Therapeutic benefits of partial splenic embolization for thrombocytopenia in hepatocellular carcinoma patients treated with radiofrequency ablation. Hepatology Research. 39(8). 772–778. 17 indexed citations
10.
Hidaka, Hisashi, Shigehiro Kokubu, Takahide Nakazawa, et al.. (2007). New angiotensin II type 1 receptor blocker olmesartan improves portal hypertension in patients with cirrhosis. Hepatology Research. 37(12). 1011–1017. 6 indexed citations
11.
Ono, Koji, Shigehiro Kokubu, Hiroshi Hidaka, et al.. (2005). Risk factors of delay in restoration of hepatic reserve capacity and local recurrence after radiofrequency ablation therapy for hepatocellular carcinoma (HCC). Hepatology Research. 31(3). 172–177. 12 indexed citations
12.
Tarao, Kazuo, Yasushi Rino, Shoji Takemiya, et al.. (2003). Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus‐associated liver cirrhosis. Cancer Science. 94(12). 1083–1090. 10 indexed citations
13.
Watanabe, Masaaki, et al.. (2001). Diagnostic value of drug lymphocyte stimulation test and evaluation of diagnostic criteria for drug induced liver injury.. Kanzo. 42(9). 448–454. 7 indexed citations
14.
Kokubu, Shigehiro, et al.. (2000). Indication and Placement of Microwave Coagulation Therapy (MCT) for the patient with hepatocellular carcinoma (HCC). Journal of Microwave Surgery. 18. 45–49.
17.
Murakami, Masato, et al.. (1992). ENDOSCOPIC VARICEALOGRAPHY DURING INJECTION SCLEROTHERAPY OF PORTO-PULMONARY VENOUS ANASTOMOSIS AND ITS COMPLICATIONS. Acta gastro-enterologica belgica. 34(11). 2543–2551. 3 indexed citations
18.
19.
Kokubu, Shigehiro, Nobuo Yamada, Akitaka Shibuya, et al.. (1986). A comparative study of two cases of adult Crigler-Najjar syndrome.. Kanzo. 27(11). 1622–1627. 1 indexed citations
20.
Kokubu, Shigehiro, et al.. (1985). Intrahepatic microvascular changes in the malignant transformation of macronodular cirrhosis in rats.. Kanzo. 26(11). 1487–1494. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026